The global medical industry experienced a 35% decline in the number of social responsibility-related patent applications in Q3 2024 compared with the previous quarter. The total number of social responsibility-related grants dropped by 27% in Q3 2024, according to GlobalData’s Patent Analytics. GlobalData’s databook ³Ô¹ÏºÚÁÏÍøs: Patents Trends Q3 2024 offers comprehensive insights into patenting trends, major players’ strategies, and geographical focus in the sector over the last three years.
Notably, the number of social responsibility-related patent applications in the medical industry was 84 in Q3 2024, versus 129 in the prior quarter.
The top five companies accounted for 15% of patenting activity
³Ô¹ÏºÚÁÏÍø of patenting activity by companies shows that Stryker filed the most social responsibility patents within the medical industry in Q3 2024. The company filed 3 social responsibility-related patents in the quarter. It was followed by Honeywell International with 3 social responsibility patent filings, Invent Medical Group (3 filings), and Kao (2 filings) in Q3 2024.
Patenting activity was driven by the US with a 20% share of total patent filings
The largest share of social responsibility related patent filings in the medical industry in Q3 2024 was in the US with 20%, followed by China (12%) and Japan (8%). The share represented by the US was 9% lower than the 29% share it accounted for in Q2 2024.
For further understanding of GlobalData's ³Ô¹ÏºÚÁÏÍøs: Patents Trends Q3 2024,
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.